New Caledonia vs Nigeria: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
New Caledonia
2.3%
in 2024
Nigeria
2.7%
in 2024
New Caledonia rank
12th
Nigeria rank
9th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- New Caledonia
- Nigeria
How they compare
Nigeria currently reports 2.7% against 2.3% in New Caledonia, a difference of 0.4%.
That makes Nigeria's figure about 1.2 times New Caledonia's.
Across all 10 years both countries report, Nigeria has been ahead every year.
New Caledonia ranks 12th and Nigeria ranks 9th of 246 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Caledonia | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 3.7% | 1.9% | Nigeria |
| 2020s | 2.2% | 3.1% | 0.9% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, New Caledonia or Nigeria?
- Nigeria, at 2.7% against 2.3% in New Caledonia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between New Caledonia and Nigeria?
- 0.4%, with Nigeria ahead.
- How many years of comparable data are there for New Caledonia and Nigeria?
- 10 years are reported by both, from 2015 to 2024.
- How do New Caledonia and Nigeria rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- New Caledonia ranks 12th and Nigeria ranks 9th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.